Organisation paid for research Program year 2020 Source: CMS Open Payments

Viking Clinical Research, Ltd.

Neither a doctor nor a teaching hospital

Research payments

$148,631

78 payments

Through program year 2020, Viking Clinical Research, Ltd. is reported as receiving $148,631 in research payments, across 78 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$42,699	30
2019	Research	$105,932	48

Breakdown

Who paid Research payments · program years 2019–2020

Alkermes, Inc. $148,631 78 payments

Studies the money was for Research payments · program years 2019–2020

A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder $89,786 53 payments
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to OLANZAPINE in Adults with Schizophrenia $37,817 3 payments
A Phase 3b Extension Study of Adjunctive ALKS5461 in the Treatment of Refractory Major DepressiveDisorder $13,897 10 payments
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 $4,531 8 payments
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects with Schizophrenia $2,599 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.